Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypnotics: an update.

Timothy Roehrs1, Thomas Roth

  • 1Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA. TARoehrs@aol.com

Current Neurology and Neuroscience Reports
|February 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying major life events associated with insomnia disorder: Stressors that disrupt safety, stability, and identity.

Sleep health·2026
Same author

Discrepancies Between Subjective and Objective Evaluation of Sleep: Potential Marker for Mild Cognitive Impairment.

Sleep medicine research·2026
Same author

Solubility, speciation and thermodynamics of Fe in reducing aqueous KCl solutions.

RSC advances·2025
Same author

Once-Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy.

Journal of sleep research·2025
Same author

A randomized controlled trial of telemedicine CBTI and PUMAS for prenatal insomnia: Reducing nocturnal cognitive arousal is a treatment mechanism for alleviating insomnia and depression during pregnancy.

Sleep medicine·2025
Same author

A Mechanistic study assessing difficulty discontinuing chronic hypnotic use.

Psychopharmacology·2025
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Benzodiazepine receptor agonists (BZRAs) effectively treat insomnia by improving sleep. Recent advances offer diverse pharmacokinetic profiles, enhancing treatment flexibility and clarifying side effect profiles.

Area of Science:

  • Pharmacology
  • Sleep Medicine
  • Drug Development

Background:

  • Benzodiazepine receptor agonists (BZRAs) are the primary pharmacotherapy for insomnia.
  • Current BZRAs improve sleep onset and maintenance.
  • Understanding their therapeutic and side-effect profiles is crucial.

Purpose of the Study:

  • To review recent advances in the therapeutic and side-effect profiles of BZRAs.
  • To highlight the impact of pharmacokinetic diversity on treatment strategies.
  • To address the long-term efficacy and safety of BZRAs.

Main Methods:

  • Literature review of recent developments in BZRA research.
  • Analysis of pharmacokinetic profiles and their clinical implications.
  • Examination of identified side effects and their determinants (dose, half-life).

Related Experiment Videos

Main Results:

  • Significant advancements in the diversity of pharmacokinetic profiles among approved BZRAs.
  • Enhanced clinician flexibility in tailoring insomnia treatment strategies.
  • Clarification of the nature, significance, and determinants of BZRA side effects.

Conclusions:

  • Diverse pharmacokinetic profiles of BZRAs increase treatment options for insomnia.
  • Understanding side effects related to dose and half-life improves patient safety.
  • Further research is needed to determine the long-term efficacy and safety of BZRAs with chronic use.